<DOC>
	<DOCNO>NCT00000809</DOCNO>
	<brief_summary>The purpose study test safety effectiveness two different formulation HIV vaccine infant bear HIV-infected woman .</brief_summary>
	<brief_title>Safety Effectiveness Two Different Formulations HIV Vaccine Infants Born HIV-Infected Women</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<mesh_term>QS 21</mesh_term>
	<criteria>Inclusion Criteria Infants may eligible study : Are 1 3 day old .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>HIV Preventive Vaccine</keyword>
	<keyword>HIV Therapeutic Vaccine</keyword>
</DOC>